Scott Carter focuses his practice on the life sciences industry, representing life sciences companies and investors in complex transactions relating to the development and commercialization of biotechnology, pharmaceutical, diagnostic, and medical-device products. He has extensive experience negotiating corporate partnership, licensing, research and development, clinical trial, manufacturing, and supply agreements. Dr. Carter also advises clients on the intellectual property aspects of mergers and acquisitions.
Dr. Carter holds a Ph.D. in chemistry from the California Institute of Technology. His research at Caltech centered on non-natural nucleosides, as well as the design, synthesis, and testing of DNA-binding molecules in the laboratory of Peter Dervan.
While at Caltech and law school, Dr. Carter was also the assistant director of the Office of Technology Transfer at Caltech. In this role, he managed the Institute’s life sciences patent portfolio, and negotiated and drafted license, research, and material transfer agreements, as well as advising Caltech entrepreneurs on new ventures.
Dr. Carter is admitted to practice in California and before the U.S. Patent and Trademark Office.
Scott Carter is listed as a Next Generation Lawyer in Technology: Transactions by Legal 500 2018.
©1996-2019 Morrison & Foerster LLP. All rights reserved.